Funding Details
- Awarder
- StartEngine
- Date Award
- February 12, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Premoney Valuation
-
$35,000,000
- Valuation
-
$35,000,000
Company Info
- Founding Year
- 1998
- Traction
- The company has successfully improved memory in mice through proof of concept trials and has received multiple small business innovation grants from the National Institutes of Health. They are currently focused on developing a device called 'Amytrapper' to trap amyloid from circulation, supported by a grant from NIA.
- Organizations Involved
- National Institutes of Health, Yale School of Medicine, Merck
- Founders
- Pazhani Sundaram
- Company Description
- Recombinant Technologies is an emerging biotechnology company.
- Market
- Alzheimer's Disease Treatment
- Location
-
Cheshire,
CT,
US
- Coinvestors
- StartEngine Capital, LLC
Links